Coya Therapeutics COYA
NASDAQ COYA
$4.01 -0.13 (-3.26%)
As of: Oct 23, 2026 · 3:16 PM EDT

Coya Therapeutics (COYA) Return on Capital Employed [ROCE] (2023 - 2026)

Updated

Coya Therapeutics' Return on Capital Employed [ROCE] was -49.49% in Q2 2026, up 22.49 percentage points from -71.98% a year earlier but down 2.64 percentage points from the prior quarter.

Analysis

Coya Therapeutics (COYA) Return on Capital Employed [ROCE] (2023 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Coya Therapeutics came in at -54.64%, down 10.39 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a three-year change of +299.55 percentage points (FY2022 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -44.25% in FY2024 (-4.29 pp), -39.96% in FY2023 (+314.23 pp) and -354.20% in FY2022.
  • Quarterly Return on Capital Employed [ROCE] has moved between -103.04% (Q3 2023) and -29.95% (Q1 2024) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in three of the last eight quarters, with an average year-over-year change of -3.96 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2024 (a gain of 70.99 percentage points); the worst was Q2 2025 (a drop of 41.94 percentage points).
  • Per Business Quant data, COYA's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -46.85% (Q1 2026), -64.21% (Q4 2025) and -70.85% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,129.96 Bn 1,098.54 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.65 Bn 555.51 Bn 17.30 Bn 17.52%
3 AbbVie 504.89 Bn 478.00 Bn 12.70 Bn 17.92%
4 Merck 358.50 Bn 312.87 Bn 12.21 Bn 6.28%
5 Novartis Ag 291.04 Bn 255.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.27 Bn 238.95 Bn 12.86 Bn 16.76%
7 Amgen 237.76 Bn 193.16 Bn 7.24 Bn 16.66%
8 Gilead Sciences 195.00 Bn 169.20 Bn 6.22 Bn -5.97%
9 Pfizer 171.37 Bn 118.02 Bn 10.94 Bn 11.86%
10 Coya Therapeutics 93.95 Mn -74.93 Mn - -49.49%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -49.49%
Mar 31, 2026 -46.85%
Dec 31, 2025 -64.21%
Sep 30, 2025 -70.85%
Jun 30, 2025 -71.98%
Mar 31, 2025 -52.50%
Dec 31, 2024 -47.75%
Sep 30, 2024 -32.05%
Jun 30, 2024 -30.05%
Mar 31, 2024 -29.95%
Dec 31, 2023 -36.71%
Sep 30, 2023 -103.04%
Jun 30, 2023 -73.49%
Mar 31, 2023 -94.60%
API Access

Coya Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=COYA&period=max&api_key=YOUR_API_KEY